{"id":"https://openalex.org/W1985133166","doi":"https://doi.org/10.1097/yic.0b013e3281c55f4f","title":"A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia","display_name":"A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia","publication_year":2007,"publication_date":"2007-08-09","ids":{"openalex":"https://openalex.org/W1985133166","doi":"https://doi.org/10.1097/yic.0b013e3281c55f4f","mag":"1985133166","pmid":"https://pubmed.ncbi.nlm.nih.gov/17690599"},"language":"en","primary_location":{"id":"doi:10.1097/yic.0b013e3281c55f4f","doi":"https://doi.org/10.1097/yic.0b013e3281c55f4f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3281c55f4f","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089587823","display_name":"R. Luthringer","orcid":"https://orcid.org/0000-0002-2819-1238","observed_orcids":["https://orcid.org/0000-0002-2819-1238"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Remy Luthringer","raw_affiliation_strings":["Executive Department, Forenap Pharma, 27 rue du 4\u00e9me RSM, Rouffach 68250, France. remy.luthringer@forenap.com","Forenap Pharma, Rouffach, France","to Remy Luthringer, PhD, Forenap Pharma, Executive Department, 27 rue du 4\u00e8me RSM, ROUFFACH, 68250, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Executive Department, Forenap Pharma, 27 rue du 4\u00e9me RSM, Rouffach 68250, France. remy.luthringer@forenap.com","institution_ids":[]},{"raw_affiliation_string":"Forenap Pharma, Rouffach, France","institution_ids":[]},{"raw_affiliation_string":"to Remy Luthringer, PhD, Forenap Pharma, Executive Department, 27 rue du 4\u00e8me RSM, ROUFFACH, 68250, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074858773","display_name":"Luc Staner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luc Staner","raw_affiliation_strings":["Forenap Pharma, Rouffach, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forenap Pharma, Rouffach, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045411598","display_name":"Nadine No\u00ebl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadine Noel","raw_affiliation_strings":["Forenap Pharma, Rouffach, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forenap Pharma, Rouffach, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009661224","display_name":"Muriel Muzet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muriel Muzet","raw_affiliation_strings":["Forenap Pharma, Rouffach, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forenap Pharma, Rouffach, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085006417","display_name":"Cristiana Gassmann-Mayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristiana Gassmann-Mayer","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110329618","display_name":"Krishna Talluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krishna Talluri","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062491149","display_name":"Adriaan Cleton","orcid":"https://orcid.org/0000-0002-7413-8585","observed_orcids":["https://orcid.org/0000-0002-7413-8585"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adriaan Cleton","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022689860","display_name":"Mari\u00eblle Eerdekens","orcid":"https://orcid.org/0000-0001-6198-4806","observed_orcids":["https://orcid.org/0000-0001-6198-4806"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marielle Eerdekens","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084476828","display_name":"Wendy Petry Battisti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy P. Battisti","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014987021","display_name":"Joseph Palumbo","orcid":"https://orcid.org/0000-0003-0609-5699","observed_orcids":["https://orcid.org/0000-0003-0609-5699"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Palumbo","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research and Development, L.L.C., New Jersey, USA","institution_ids":["https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089587823"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.5781,"has_fulltext":false,"cited_by_count":95,"citation_normalized_percentile":{"value":0.98235863,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"22","issue":"5","first_page":"299","last_page":"308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.8310999870300293,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.8310999870300293,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.16359999775886536,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10985","display_name":"Sleep and Wakefulness Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paliperidone-extended-release","display_name":"paliperidone extended-release","score":0.9929999709129333},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8859999775886536},{"id":"https://openalex.org/keywords/insomnia","display_name":"insomnia","score":0.875},{"id":"https://openalex.org/keywords/sleep-architecture","display_name":"sleep architecture","score":1.0},{"id":"https://openalex.org/keywords/sleep-continuity","display_name":"sleep continuity","score":0.7369999885559082},{"id":"https://openalex.org/keywords/sleep-onset-latency","display_name":"sleep latency","score":0.7910000085830688},{"id":"https://openalex.org/keywords/rem-sleep-duration","display_name":"REM sleep duration","score":0.6869999766349792},{"id":"https://openalex.org/keywords/sleep-efficiency","display_name":"sleep efficiency","score":0.6660000085830688},{"id":"https://openalex.org/keywords/daytime-somnolence","display_name":"daytime somnolence","score":0.9570000171661377}],"concepts":[{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.8565951585769653},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7503042817115784},{"id":"https://openalex.org/C63759246","wikidata":"https://www.wikidata.org/wiki/Q7539762","display_name":"Sleep onset","level":3,"score":0.7192461490631104},{"id":"https://openalex.org/C2781053850","wikidata":"https://www.wikidata.org/wiki/Q7539763","display_name":"Sleep onset latency","level":4,"score":0.649340033531189},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.5918402671813965},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5486850738525391},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46903786063194275},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4368700385093689},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.42818787693977356},{"id":"https://openalex.org/C2778205975","wikidata":"https://www.wikidata.org/wiki/Q1754874","display_name":"Polysomnography","level":3,"score":0.4274333715438843},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4153480529785156},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3646284341812134},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23349261283874512},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.21449998021125793},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.18330103158950806},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.10705932974815369},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2781326671","wikidata":"https://www.wikidata.org/wiki/Q754424","display_name":"Apnea","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012894","descriptor_name":"Sleep Stages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012894","descriptor_name":"Sleep Stages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012894","descriptor_name":"Sleep Stages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017286","descriptor_name":"Polysomnography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017286","descriptor_name":"Polysomnography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017286","descriptor_name":"Polysomnography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/yic.0b013e3281c55f4f","doi":"https://doi.org/10.1097/yic.0b013e3281c55f4f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3281c55f4f","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:17690599","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17690599","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7400000095367432,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1555810878","https://openalex.org/W1939484047","https://openalex.org/W1965458709","https://openalex.org/W1968863819","https://openalex.org/W1977440619","https://openalex.org/W1979700184","https://openalex.org/W1998328835","https://openalex.org/W1999689270","https://openalex.org/W2004185689","https://openalex.org/W2005457043","https://openalex.org/W2018590161","https://openalex.org/W2023973601","https://openalex.org/W2027524208","https://openalex.org/W2049434366","https://openalex.org/W2057254548","https://openalex.org/W2065518071","https://openalex.org/W2073797983","https://openalex.org/W2087505840","https://openalex.org/W2090581304","https://openalex.org/W2124713283","https://openalex.org/W2131658797","https://openalex.org/W2136374206","https://openalex.org/W2140606211","https://openalex.org/W2143017058","https://openalex.org/W2148347826","https://openalex.org/W2165379748","https://openalex.org/W4251090728"],"related_works":["https://openalex.org/W2766260471","https://openalex.org/W2733183022","https://openalex.org/W4238856825","https://openalex.org/W4313648910","https://openalex.org/W2517946129","https://openalex.org/W2010169228","https://openalex.org/W2121155664","https://openalex.org/W2086020622","https://openalex.org/W7025705924","https://openalex.org/W2886630620"],"abstract_inverted_index":{"The":[0],"effects":[1],"of":[2,113,179],"paliperidone":[3,24,67],"extended-release":[4,25,80,182],"on":[5,66,70],"sleep":[6,39,46,92,103,107,116,128,135,139,146,154,162,188,191],"architecture":[7,37,189],"in":[8,15,85,91,121,161,193],"patients":[9,64,194],"with":[10,169,196],"schizophrenia-related":[11],"insomnia":[12],"were":[13,41,48,60],"evaluated":[14,42,49],"this":[16],"multicenter,":[17],"double-blind,":[18],"randomized,":[19],"placebo-controlled":[20],"study.":[21,78],"Patients":[22],"received":[23],"9":[26],"mg/day":[27],"or":[28],"matching":[29],"placebo":[30,83],"during":[31],"the":[32,52,77],"14-day":[33],"double-blind":[34],"phase.":[35],"Sleep":[36,54],"and":[38,58,87,125,150,158,176,186,190,198],"continuity":[40,192],"using":[43,51],"polysomnograms.":[44],"Subjective":[45],"measures":[47],"daily":[50],"Leeds":[53],"Evaluation":[55],"Questionnaire.":[56],"Efficacy":[57],"safety":[59],"also":[61],"assessed.":[62],"Thirty-six":[63],"(17":[65],"extended-release,":[68,167],"19":[69],"placebo;":[71],"mean":[72],"age":[73],"32.2":[74],"years)":[75],"completed":[76],"Paliperidone":[79,166,181],"treatment":[81],"vs.":[82],"resulted":[84],"clinically":[86],"statistically":[88],"significant":[89],"differences":[90],"measurements":[93],"from":[94],"baseline":[95],"to":[96],"endpoint":[97],"including":[98],"a":[99],"reduction":[100],"in:":[101,133],"persistent":[102],"latency":[104,109],"(41":[105],"min),":[106,111,124,138,143,149],"onset":[108,117],"(35":[110],"number":[112],"awakenings":[114],"after":[115],"(7),":[118],"time":[119,136,141],"awake":[120],"bed":[122],"(50":[123],"stage":[126,144],"1":[127],"duration":[129,147,155],"(12":[130],"min);":[131,157],"prolongation":[132],"total":[134],"(53":[137],"period":[140],"(42":[142],"2":[145],"(51":[148],"rapid":[151],"eye":[152],"movement":[153],"(18":[156],"an":[159],"increase":[160],"efficiency":[163],"index":[164],"(11%).":[165],"compared":[168],"placebo,":[170],"did":[171],"not":[172],"exacerbate":[173],"daytime":[174],"somnolence":[175],"improved":[177,187],"symptoms":[178],"schizophrenia.":[180],"was":[183],"well":[184],"tolerated":[185],"diagnosed":[195],"schizophrenia":[197],"concomitant":[199],"insomnia.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}